Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

[HTML][HTML] Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review

T Harder, O Wichmann, SJ Klug, MAB van der Sande… - BMC medicine, 2018 - Springer
Background Human papillomavirus (HPV) vaccination is safe and effective in preventing
cervical cancer in females. As HPV infections can also induce cancers of the anus, penis …

Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology

WJ Koh, NR Abu-Rustum, S Bean, K Bradley… - Journal of the National …, 2019 - jnccn.org
Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of
cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine …

[BOOK][B] Current medical diagnosis & treatment 2010

SJ McPhee, MA Papadakis, MW Rabow - 2010 - academia.edu
Current Medical Diagnosis and Treatment 2012 Page 1 Current Medical Diagnosis and
Treatment 2012 McPhee, Stephen J. MD ISBN-13: 9780071763721 Table of Contents Table of …

[HTML][HTML] Evidence-based clinical guidelines for immigrants and refugees

K Pottie, C Greenaway, J Feightner, V Welch… - Cmaj, 2011 - Can Med Assoc
Health: Deborah Assayag, Elizabeth Barnett, Jennifer Blake, Beverly Brockest, Giovani
Burgos, Glenn Campbell, Andrea Chambers, Angie Chan, Maryann Cheetham, Walter …

Cervical cancer, version 2.2015

WJ Koh, BE Greer, NR Abu-Rustum, SM Apte… - Journal of the National …, 2015 - jnccn.org
The NCCN Guidelines for Cervical Cancer provide interdisciplinary recommendations for
treating cervical cancer. These NCCN Guidelines Insights summarize the NCCN Cervical …

Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 …

MH Einstein, M Baron, MJ Levin, A Chatterjee… - Human …, 2009 - Taylor & Francis
This observer-blind study compared the prophylactic human papillomavirus (HPV) vaccines,
Cervarix™(GlaxoSmithKline) and Gardasil®(Merck), by assessing immunogenicity and …

[HTML][HTML] Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis

B Lu, A Kumar, X Castellsagué, AR Giuliano - BMC infectious diseases, 2011 - Springer
Background We conducted a systematic review and meta-analysis to assess efficacy and
safety of prophylactic HPV vaccines against cervical cancer precursor events in women …

[HTML][HTML] The clinical development process for a novel preventive vaccine: An overview

K Singh, S Mehta - Journal of postgraduate medicine, 2016 - journals.lww.com
Each novel vaccine candidate needs to be evaluated for safety, immunogenicity, and
protective efficacy in humans before it is licensed for use. After initial safety evaluation in …

Cervical cancer

WJ Koh, BE Greer, NR Abu-Rustum, SM Apte… - Journal of the National …, 2013 - jnccn.org
These NCCN Clinical Practice Guidelines in Oncology for Cervical Cancer focus on early-
stage disease, because it occurs more frequently in the United States. After careful clinical …